Talk:Brain natriuretic peptide 32
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Brain natriuretic peptide 32 article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Brain natriuretic peptide 32.
|
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Name
"Ventricular natriuretic peptide" is the newer and more accurate name that is substituting the old term. I have transferred all the information on the new page. However, there is an error regarding infobox data transfer and I don't know how to fix it. Please help to fix it. I appreciate you taking the time to fix that error Behzad Azarmju M.D. (talk) 11:36, 14 December 2019 (UTC).
NYHA undefined
The acronym NYHA is a prominent feature of the table that appears in this article. It is not defined.Rdphair (talk) 20:55, 19 March 2021 (UTC)
What has this to do with the brain?
Can the article explain the relationship between natriuretic peptide and the brain? I.e., why is it called “brain natriuretic peptide”? 138.88.146.163 (talk) 21:58, 21 July 2021 (UTC)